FDA Accepts LEQEMBI (Lecanemab-Irmb) Biologics License Application For Subcutaneous ...
( MENAFN - JCN NewsWire) FDA Accepts LEQEMBI (lecanemab-irmb) Biologics License Application for Subcutaneous Maintenance Dosing for the treatment of Early Alzheimer's disease LEQEMBI is the only ...
Obesity won’t be solely defined by BMI under new plan for diagnosis by global experts
BMI has long been considered a flawed measure that can over-diagnose or underdiagnose obesity, which is currently defined as ...